January 15, 2026 · PRODUCTS
Jieruo Vascular Interventional Robot
First-generation PCI surgical robot from Jieruo Medical featuring sub-millimeter precision for coronary stent placement and catheter-based interventions.
›#Vascular-Interventional
29 articles
January 15, 2026 · PRODUCTS
LiqMagic Coronary Intravascular Lithotripsy System
Coronary intravascular lithotripsy (IVL) system for treating calcified coronary artery lesions, NMPA approved October 2023; described by the manufacturer as China's first domestically developed coronary IVL platform.
›January 15, 2026 · PRODUCTS
PANVIS Star Pan-Vascular Interventional System
Next-generation pan-vascular interventional robot from Abrobo covering coronary, peripheral, and neurovascular procedures with full-procedure robotic control.
›January 15, 2026 · PRODUCTS
PANVIS-A NeuroInterventional Robotic System
NMPA-approved neurointerventional robot enabling radiation-free cerebral angiography, developed by Abrobo with COF fingertip control technology.
›January 15, 2026 · COMPANIES
RainMed Medical
Hong Kong-listed vascular interventional robotics company developing AI-powered coronary diagnostic systems and surgical robots.
›January 15, 2026 · COMPANIES
Shuzhidao
Shanghai-based platform surgical robot company developing dental implant, hair transplant, and vascular interventional systems.
›January 15, 2026 · COMPANIES
Sonosemi Medical
Shenzhen-based medical device company developing intravascular lithotripsy systems and ultrasound imaging solutions for pan-vascular disease treatment.
›January 15, 2026 · COMPANIES
WeMed
Beijing-based interventional medical device company developing vascular intervention robots, DSA systems, and mobile C-arms for minimally invasive surgery.
›March 21, 2025 · NEWS
ETcath Wins NMPA Approval as China's First Fully Domestic Coronary Interventional Robot
WeMed Medical's ETcath received NMPA approval March 21, 2025, becoming China's first fully domestically developed robot for percutaneous coronary intervention.
›